期刊文献+

不同剂量米非司酮与MTX联合治疗未破裂型异位妊娠的临床观察 被引量:14

Clinical Observation of Unruptured Ectopic Pregnancy Treated by Mifepristone and MTX
下载PDF
导出
摘要 目的探讨不同剂量米非司酮与MTX联合治疗未破裂型异位妊娠的临床效果。方法回顾性分析2005年3月至2009年8月在南湾人民医院采用不同保守治疗方案的未破裂型异位妊娠患者156例,总结分析不同剂量米非司酮与MTX联合治疗的保守治疗效果。结果较大剂量米非司酮联合治疗组的治愈率明显高于小剂量米非司酮联合治疗及单一用MTX治疗两组,比较差异具有统计学意义(P<0.01),小剂量米非司酮联合治疗组的治愈率高于单一用MTX治疗组,比较差异具有统计学意义(P<0.05),药物不良反应方面,MTX剂量加大具有骨髓抑制作用,而加大米非司酮剂量在不良反应方面无显著差异,比较差异无统计学意义(P>0.05)。结论较大剂量米非司酮与MTX联合治疗未破裂型异位妊娠,可有效提高疗效,且不增加药物不良反应。 Objective To explore effect of different doses of mifepristone combined with MTX treatment of unruptured ectopic pregnancy.Method Retrospective analysis from March 2005 to August 2009 in Nanwan hospital from different conservative treatment programs in patients with un-ruptured ectopic pregnancy 156 cases,Summary analysis of different doses of mifepristone and MTX combination therapy of conservative treatment.Result Larger doses of mifepristone combined treatment group of cure rate is significantly higher than small doses combined treatment and single use MTX therapy two groups,Comparison difference statistically significance(P0.01),Small doses of mifepristone treatment,the cure rates higher than the single treatment group with MTX,Comparison difference statistically significance(P0.05),About drug side effects,MTX dose increases with bone marrow suppression,Increase the dose of mifepristone was no significant difference in side effects,No statistical significance(P0.05).Conclusion Larger doses of mifepristone combined with MTX treatment of unruptured ectopic pregnancy,can effectively improve effectiveness,and does not increase adverse drug reactions.
出处 《中国医药指南》 2010年第26期13-15,共3页 Guide of China Medicine
关键词 异位妊娠 药物疗法 米非司酮 甲氨蝶呤 Ectopic pregnancy Drug therapy Mifepristone Methotrexate
  • 相关文献

参考文献7

二级参考文献35

  • 1刘珠凤,郎景和,黄荣丽,连利娟,张德永.氨甲喋呤单次肌内注射治疗异位妊娠[J].中华妇产科杂志,1996,31(8):490-492. 被引量:381
  • 2茅惠明,临床检验杂志,1995年,13卷,6页
  • 3桑国卫,中华妇产科杂志,1994年,29卷,735页
  • 4Chan CC, Lao TT, Cheung AN. Apoptotic and proliferative activities in first trimester placentae. Placena, 1999,20(2-3): 223-227.
  • 5Guller S, LaChapelle L. The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces. Semin Reprod Endocrinol, 1999,17:39-44.
  • 6Rotello RJ,Hocker MB,Gerschenson LE. Biochemical evidence for programmed cell death in rabbit uterine epithelium. Am J Pathol,1989,134:491-495.
  • 7Korsmeyer SJ, Shutter JR, Veis DJ, et al. Bcl-2/Bax:a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol, 1993,4: 327-332.
  • 8Heikinheimo O, Hsiu JG, Gordon K, et al. Endometrial effects of mifepriston in primates: antiproliferative action despite signs of estrogen action and increased cyclin-B expression. J Steroid Biochem Mol Biol, 1996, 59: 179-190.
  • 9Rashid M,Osman SH,Khashoggi TY,et al.Factors affecting fertility following radical versus conservitive surgical treatment for tubal pregnancy[J].Saudi Med J,2001,22(4):337.
  • 10Giuliani A,Hoenigl W,Schoell W,et al.Reproductive outcome after laparoscopic instillation of hyperosmolar glucose into unrruptured tubal pregnancies[J].Fertil Steril,2001,76(2):366.

共引文献226

同被引文献72

引证文献14

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部